Psychopharmacology Reconsidered: A Concise Guide Exploring the Limits of Diagnosis and Treatment

★★★★★ 4.4 63 reviews

US$17.93
Price when purchased online
Free shipping Free 30-day returns

Sold and shipped by polycontact.ro
We aim to show you accurate product information. Manufacturers, suppliers and others provide what you see here.
US$17.93
Price when purchased online
Free shipping Free 30-day returns

How do you want your item?
You get 30 days free! Choose a plan at checkout.
Shipping
Arrives Jul 6
Free
Pickup
Check nearby
Delivery
Not available

Sold and shipped by polycontact.ro
Free 30-day returns Details

Product details

Management number 231985514 Release Date 2026/06/18 List Price US$17.93 Model Number 231985514
Category

This  thought-provoking book covers the full range of psychopharmacologic practice in textbook fashion, offering a fresh and comprehensive self-examination.  Unlike conventional texts of psychopharmacology, this text speaks directly to clinicians who have started to question the limitations of psychopharmacologic claims and the rigid confines of DSM-5 diagnoses. Drawing from their clinical and research experience as well as new literature, the well-published authors provide a new perspective that encourages readers to reevaluate established practices and embrace that medication is just one component of treatment and has limits. The book could be used by psychiatric residents in their course of study, by clinical psychology students taking a psychopharmacology course, or by psychiatrists curious to get a readable but comprehensive look at new critical viewpoints in psychopharmacology that have changed since they were taught. Many neuroscience students who are looking for areview of clinical effects to guide their basic research may also find the proposed text more useful than those texts that collate clinical trials.Current texts are for specialized scientists or are part of multi-authored texts which list drugs alphabetically with no conceptual framework, or books that pretend that each biochemical drug property has a clear and known clinical result presented in cartoon style.  Some lesser known texts for psychology or nursing students are not authoritative. Others aimed at patients or families are too simplistic for clinicians. The authors’ goal was to create a unified text expressing their view of psychopharmacology, its evidence base, the unity of its essential principles, and its independence of DSM or ICD diagnosis.Several new history books describe the "rise and fall" of psychopharmacology, the corruption of big pharma and the failure of large controlled clinical trials.  Psychopharmacology Reconsidered: A Concise Guide Exploring the Limits of Diagnosis and Treatment ensures that young clinicians are aware of and understand this critical zeitgeist but aware also of the essential core of psychopharmacology and the evidence upon which it rests. Read more

ASIN B0CCX95WYL
XRay Not Enabled
ISBN13 978-3031403712
Language English
File size 7.3 MB
Page Flip Enabled
Publisher Springer
Word Wise Enabled
Print length 186 pages
Accessibility Learn more
Screen Reader Supported
Publication date October 18, 2023
Enhanced typesetting Enabled

Correction of product information

If you notice any omissions or errors in the product information on this page, please use the correction request form below.

Correction Request Form

Customer ratings & reviews

4.4 out of 5
★★★★★
63 ratings | 26 reviews
How item rating is calculated
View all reviews
5 stars
81% (51)
4 stars
5% (3)
3 stars
2% (1)
2 stars
1% (1)
1 star
11% (7)
Sort by

There are currently no written reviews for this product.